RecruitingPhase 1NCT06773481

BC008-1A Injection for Recurrent CNS WHO G4 Glioma

Studying Glial tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
Intervention
BC008-1A(biological)
Enrollment
40 target
Eligibility
18 years · All sexes
Timeline
20252026

Study locations (1)

Collaborators

Beijing Tiantan Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06773481 on ClinicalTrials.gov

Other trials for Glial tumor

Additional recruiting or active studies for the same condition.

See all trials for Glial tumor

← Back to all trials